FROM THE CONFERENCE ON RETROVIRUSES AND OPPORTUNISTIC INFECTIONS
Dr. Cotter disclosed no relevant conflicts of interest. The PREPARE trial was supported by an unrestricted scientific grant from Gilead Sciences.
